Cydan Development
Cydan Development is the first orphan drug accelerator dedicated to advancing therapies that improve the lives of patients with rare genetic diseases.
Cydan identifies and de-risks drug candidates and forms stand-alone companies and strategic partnerships to support the successful development of the most promising drug candidates. Vtesse, Imara, and Tiburio are among the company spinouts from Cydan.
Relateret nyheder om Cydan Development
